| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.8 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |